Results 151 to 160 of about 840,189 (237)

Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol. [PDF]

BMC Neurol, 2023
Ros LAA, Goedee HS, Franssen H, Asselman FL, Bartels B, Cuppen I, van Eijk RPA, Sleutjes BTHM, van der Pol WL, Wadman RI.   +9 more
europepmc   +1 more source

Feasibility of combined treatment for type III spinal muscular atrophy: a pilot study

, 2017
Nataliia Sych, 1 Mariya Klunnyk,1 Iryna Matiyashchuk,1 Mariya Demchuk,1 Olena Ivankova,1 Andriy Sinelnyk,1 Khrystyna Sorochynska,2 Marina Skalozub3 1Clinical Department, 2Stem Cells Bank, 3Laboratory and Biotechnology Department, Cell Therapy Center ...
Sych N, Matiyashchuk I, Sorochynska K, Klunnyk M, Sinelnyk A, Skalozub M, Ivankova O, Demchuk M   +7 more
core  

Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers. [PDF]

Pharmacoeconomics, 2022
Sutherland CS, Hudson P, Mitchell S, Paracha N.   +3 more
europepmc   +1 more source

Ancient Schwannoma in the Nasal Cavity—A Rare Case Report With Brief Literature Review

Eye &ENT Research, Volume 3, Issue 3, Page 179-185, September 2026.
Shikhar Chohan, Annmy Jose, Sufian Zaheer   +2 more
wiley   +1 more source

Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment. [PDF]

Orphanet J Rare Dis, 2021
Monnette A, Chen E, Hong D, Bazzano A, Dixon S, Arnold WD, Shi L.   +6 more
europepmc   +1 more source

Psychological symptoms in individuals with Spinal Muscular Atrophy (SMA) and their caregivers - results from a nation-wide study in Germany. [PDF]

Orphanet J Rare Dis
Hussong J, Leibrock B, Huelle T, Mattheus H, Landfeldt E, Thiele S, Walter MC, Zemlin M, Moehler E, Dillmann U, Flotats-Bastardas M.   +10 more
europepmc   +1 more source

Evaluation of putative CSF biomarkers in paediatric spinal muscular atrophy (SMA) patients before and during treatment with nusinersen. [PDF]

J Cell Mol Med, 2021
Johannsen J, Weiss D, Daubmann A, Schmitz L, Denecke J.   +4 more
europepmc   +1 more source

Patient-reported clinical characteristics and healthcare utilization in Spinal Muscular Atrophy (SMA): a cross-sectional study from Iran. [PDF]

Orphanet J Rare Dis
Montazeri B, Daroudi R, Darvishi A, Heidari M, Anabi M, Heshmat R.   +5 more
europepmc   +1 more source

Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA). [PDF]

Int J Mol Sci, 2021
Feng Z, Lam S, Tenn ES, Ghosh AS, Cantor S, Zhang W, Yen PF, Chen KS, Burden S, Paushkin S, Ayalon G, Ko CP.   +11 more
europepmc   +1 more source

A novel case report of spinal muscular atrophy with progressive myoclonic epilepsy from Iran

, 2019
Reza Shervin Badv,1 Yalda Nilipour,2 Shahram Rahimi-Dehgolan,3 Ali Rashidi-Nezhad,4 Masood Ghahvechi Akbari51Children’s Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences (TUMS), Tehran, Iran; 2Pediatric ...
Shervin Badv R, Ghahvechi Akbari M, Rahimi-Dehgolan S, Rashidi-Nezhad A, Nilipour Y   +4 more
core